Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | PPARG | P37231 | 7/20 | 0.50 |
| ▸ | PPARD | Q03181 | 7/20 | 0.50 |
| ▸ | PPARA | Q07869 | 7/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12970907 | 1.00 | KMT2A (0.56) | KMT2AMAPTTSHRLMNANFKB1 | |
| SCHEMBL11519181 | 1.00 | KMT2A (0.56) | KMT2AMAPTTSHRLMNANFKB1 | |
| SCHEMBL29114066 | 0.98 | LMNA (0.52) | KMT2AMAPTTSHRLMNANFKB1 | |
| SCHEMBL526017 | 0.83 | EGLN1 (0.48) | LMNAALDH1A1TDP1OR51E2 | |
| SCHEMBL13879345 | 0.83 | ALDH1A1 (0.48) | TSHRALDH1A1TDP1SLC22A6 | |
| SCHEMBL11211450 | 0.83 | KMT2A (0.52) | KMT2AMAPTTSHRLMNANFKB1 | |
| SCHEMBL11329317 | 0.83 | KMT2A (0.52) | KMT2AMAPTTSHRLMNANFKB1 | |
| SCHEMBL16431422 | 0.82 | KMT2A (0.56) | KMT2AMAPTTSHRLMNAGPR84 | |
| SCHEMBL2533531 | 0.82 | ALDH1A1 (0.39) | KMT2AMAPTLMNAALDH1A1TDP1 | |
| SCHEMBL2527251 | 0.82 | ALDH1A1 (0.39) | KMT2AMAPTLMNAALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7129366-B2 | Group of a novel anti-cancer compounds with specific structure | YANG'S BIOCHEM CO. LTD. (US) | 2006-10-31 | — | — | US | claimed |
| US-20040204599-A1 | Group of novel anti-cancer compounds with specific structure | YANG'S BIOCHEM CO. LTD. | 2004-10-14 | — | — | US | claimed |
| CN-1343650-A | Anticancer compound with particular structure | YANG ZHENHUA (CN) | 2002-04-10 | — | — | CN | claimed |
| US-7129366-B2 | Group of a novel anti-cancer compounds with specific structure | YANG'S BIOCHEM CO. LTD. (US) | 2006-10-31 | — | — | US | disclosed |
| EP-1463707-A4 | A GROUP OF NOVEL ANTI-CANCER COMPOUNDS WITH SPECIFIC STRUCTURE | YANG ZHENHUA (US) | 2006-02-01 | — | — | EP | disclosed |
| US-20040204599-A1 | Group of novel anti-cancer compounds with specific structure | YANG'S BIOCHEM CO. LTD. | 2004-10-14 | — | — | US | disclosed |
| EP-1463707-A2 | A GROUP OF NOVEL ANTI-CANCER COMPOUNDS WITH SPECIFIC STRUCTURE | Yang, Zhenhua (US) | 2004-10-06 | — | — | EP | disclosed |
| WO-2003014296-A2 | A GROUP OF NOVEL ANTI-CANCER COMPOUNDS WITH SPECIFIC STRUCTURE | YANG ZHENHUA (US) | 2003-02-20 | — | — | WO | disclosed |
| CN-1343650-A | Anticancer compound with particular structure | YANG ZHENHUA (CN) | 2002-04-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204599-A1 | Group of novel anti-cancer compounds with specific structure | FASN, NFKBIA, NFATC1 | KMT2A 2693/4885MAPT 4177/4885TSHR 4370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.